IV Bags Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

IV Bags Market: By Product Type (Single Chamber IV Bags, Multi-Chamber IV Bags), By Material Type (Polypropylene, Polyvinylchloride (PVC), Ethylene Vinyl Acetate, Copolyester Ether), By Size (500-1000 ml, 250-500 ml, Up to 250 ml), By Application (Blood Storage, Blood Transfusions, Medications, Electrolyte Imbalance), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography

 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

IV Bags Market size was estimated at USD 2.6 billion in 2021, growing at a CAGR of 10.2% during the forecast period 2022-2028. IV bags are used in intravenous therapy to provide life-sustaining IV fluids, medications, and electrolytes to the patients. In intravenous therapy liquid directly enters the vein and shows faster therapeutic action compared to oral therapy. Generally, polypropylene bags are used as IV bags due to their inert nature. Global IV bags market growing at a significant rate owing to an increase in the geriatric population leading to an increase in the prevalence of chronic diseases and the need for long-term treatment for these diseases. Most of the market players are actively involved in the development of newer products for intravenous therapy. Moreover, product approval, product launches, acquisitions and mergers, and collaborations are the key strategies adopted by the market players for dominating the IV bags market.

Key Developments:

In August 2017, Fresenius Kabi Canada launched Moxifloxacin Injection 1.6mg/mL freeflex Bag 250 mL

In November 2016, Mallinckrodt Pharmaceuticals received FDA prior approval supplement for Ofirmev (Acetaminophen) injection available in IV bag.

In December 2014, Taiho Pharmaceutical Co., Ltd., received approval for the manufacture and marketing of Zosyn 4.5 for IV bag, that contains injectable antibiotic with β-lactamase inhibitor.

IV Bags Market

MARKET SUMMARY
-
10.2% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 20211
  • CAGR– 10.2%
  • Largest Market– North America
  • Fastest Growing Market–  Asia Pacific

IV Bags Market

  • The global IV bags Market report gives historical, current, and future market sizes (US$ Mn) based on product type, material type, size, application, distribution channel, and regions.
  • The IV bags Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • ICU Medical, Inc. (U.S.)
  • Medline Industries, Inc. (U.S.)
  • Kraton Corporation (U.S.)
  • Braun Melsungen AG (Germany)
  • Hospira Inc. (Pfizer, Inc.) (U.S.)
  • Otsuka Pharmaceutical Co. Ltd. (Japan)
IV Bags Market Growth

Rise in adoption of intravenous therapy, increase in the prevalence of chronic diseases, and rise in aging population are anticipated to fuel the IV bags market. Moreover, rise in awareness about advantages of intravenous therapy, affordability and availability, and growing demand for storage of blood and other blood products are anticipated to propel the IV bags market over the forecast timeframe. However, stringent regulatory policies, risk of infection and injuries to vein due to long-term administration of needle, improper monitoring of intravenous therapy, and alternatives for IV bags such as glass and plastic bottles may hamper the growth of IV bags market over the forecast timeframe.


North-America got significant share

IV Bags Market

Geographically, IV bags market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America IV bags market is driven by increase in the prevalence of chronic diseases such as cancer and rise in R&D for innovation of newer medications. Europe IV bags market has a lucrative growth owing to well-developed healthcare infrastructure, high adoption of intravenous therapy, and increase in the prevalence of chronic diseases coupled with innovation of newer medicines are anticipated to bolster the market. Asia Pacific IV bags market has a significant share owing to increase in geriatric population in India, China, and Japan, rise in medical tourism in Asia Pacific region, and increase in awareness about intravenous therapy. Latin America IV bags market is growing at a significant CAGR owing to increase in the prevalence of chronic diseases, economic growth, and adoption of newer intravenous medications are boost the market. Middle East and Africa IV bags market has a lucrative growth, which is attributed to expansion of the business by market players, increase in the incidence of malnutrition cases, and rise in healthcare expenditure.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The IV bags market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Segmentation

IV Bags Market


Location

GEOGRAPHY

Frequently Asked Questions

The IV Bags Market is projected to expand at a CAGR of 10.2% during the forecast period.

ICU Medical, Inc., Medline Industries, Inc., Kraton Corporation, Braun Melsungen AG, Hospira Inc., Otsuka Pharmaceutical Co. Ltd.

Asia Pacific is the fastest-growing region for the IV Bags Market


Report

Table Of Content

 


Report

Company Profile

  • ICU Medical, Inc. (U.S.)
  • Medline Industries, Inc. (U.S.)
  • Kraton Corporation (U.S.)
  • Braun Melsungen AG (Germany)
  • Hospira Inc. (Pfizer, Inc.) (U.S.)
  • Otsuka Pharmaceutical Co. Ltd. (Japan)
  • Haemotronic S.p.A (Italy)
  • Wipak Group (Germany)
  • Fresenius SE & Co. KGaA (Germany)
  • Polycine GmbH (Germany)

Description

IV Bags Market size was estimated at USD 2.6 billion in 2021, growing at a CAGR of 10.2% during the forecast period 2022-2028. IV bags are used in intravenous therapy to provide life-sustaining IV fluids, medications, and electrolytes to the patients. In intravenous therapy liquid directly enters the vein and shows faster therapeutic action compared to oral therapy. Generally, polypropylene bags are used as IV bags due to their inert nature. Global IV bags market growing at a significant rate owing to an increase in the geriatric population leading to an increase in the prevalence of chronic diseases and the need for long-term treatment for these diseases. Most of the market players are actively involved in the development of newer products for intravenous therapy. Moreover, product approval, product launches, acquisitions and mergers, and collaborations are the key strategies adopted by the market players for dominating the IV bags market.

Key Developments:

In August 2017, Fresenius Kabi Canada launched Moxifloxacin Injection 1.6mg/mL freeflex Bag 250 mL

In November 2016, Mallinckrodt Pharmaceuticals received FDA prior approval supplement for Ofirmev (Acetaminophen) injection available in IV bag.

In December 2014, Taiho Pharmaceutical Co., Ltd., received approval for the manufacture and marketing of Zosyn 4.5 for IV bag, that contains injectable antibiotic with β-lactamase inhibitor.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX